Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Genome editing

10.06.2022

Improved CRISPR to edit insects genome

16.12.2021

4.5M€ for the development of state-of-the-art genetic engineering technologies

A debate on the ethical implications of using CRISPR to edit the human genome took place at the PRBB.
14.12.2021

The ethics of CRISPR: a necessary debate

How do we decide when and if we should use the new genome editing technologies, whose impact may be noticed in future generations?
18.08.2020

Genome editing with CRISPR

16.04.2020

Study of genetic oscillations of the segmentation clock sheds some light into a disease of the vertebrae

The iGEM team after their presentation of the project at the competition in Boston (From left to right: Marc Güell, Avencia Sánchez-Mejías, Marta Vilademunt, Óscar Rodríguez, Laura Sans, Jordi Pla, Dimitrije Ivančić, Eva Gonzalez, Guillem Lopez-Grado, Carla Castignani and Oriol Solà).
01.02.2019

GARGANTUA: the modified bacteria to prevent metastasis

Marc Güell, head of the Translational Synthetic Biology research group at DCEXS-UPF.
10.01.2018

Marc Güell (DCEXS-UPF): “Living matter is the most advanced machinery that exists”

The Spanish microbiologist, and CRISPR discoverer, Francisco J.M. Mojica, received the Jaime I Award for Basic Research, due to his discovery.
30.07.2016

Francisco Mojica: “I’m incredibly proud of having been part of the CRISPR revolution”

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2026 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org